FDA Guidance Documents·· 原文未提供具体时分
Technical Considerations for Demonstrating Reliability of Emergency-Use Injectors Submitted under a BLA, NDA or ANDA: Draft Guidance for Industry and Food and Drug Administration Staff
Technical Considerations for Demonstrating Reliability of Emergency-Use Injectors Submitted under a BLA, NDA or ANDA: Draft Guidance for Industry and Food and Drug Administration Staff
AI 导读
FDA 官方历史目录记录；Draft guidance；发布日期：2020-04-21。官方主题：Combination Products。请通过官方原文与附件查阅文件。
来源：FDA Guidance Documents · fda.gov